Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle

Neuromuscular Disorders

Volumn 20, Issue 12, 2010, Pages 820-825

  Guo, Ling T ^a   Moore, Steven A ^b   Forcales, Sonia ^c   Engvall, Eva ^c   Diane Shelton, G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Dysferlin; Immunostaining; Muscular dystrophy

Indexed keywords

ACETONE; DYSFERLIN; METHANOL; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DYSFERLIN DEFICIENCY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SARCOLEMMA; SEQUENCE ALIGNMENT; SKELETAL MUSCLE; TISSUE FIXATION;

ANIMALS; ANTIBODIES; DOGS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL;

EID: 78650172355     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.07.278     Document Type: Article

References (24)

1. Cohn R.D., Campbell K.P. The molecular basis of muscular dystrophies. Muscle Nerve 2000, 23:1456-1471.
2. Bornemann A., Anderson L.V.B. Diagnostic protein expression in human muscle biopsies. Brain Pathol 2000, 10:193-214.
3. Deitz K., Morrison J.A., Kline K., Guo L.T., Shelton G.D. Sarcoglycan-deficient muscular dystrophy in a Boston terrier. J Vet Intern Med 2008, 22:476-480.
4. Wieczorek L.A., Garosi L.S., Shelton G.D. Dystrophin-deficient muscular dystrophy in an old English sheepdog. Vet Rec 2006, 25:270-273.
5. Jones B.R., Brennan S., Mooney C.T., et al. Muscular dystrophy with truncated dystrophin in a family of Japanese spitz dogs. J Neurol Sci 2004, 217:143-149.
6. Bergman R.L., Inzana K.D., Monroe W.E., et al. Dystrophin-deficient muscular dystrophy in a Labrador retriever. J Am Anim Hosp Assoc 2002, 38:255-261.
7. Shelton G.D., Liu L.A., Guo L.T., et al. Muscular dystrophy in female dogs. J Vet Intern Med 2001, 15:240-244.
8. Moore S.A., Shilling C.J., Westra S., et al. Limb-girdle muscular dystrophy in the USA. J Neuropathol Exp Neurol 2006, 65:995-1003.
9. Poncelet L., Résibois A., Engvall E., Shelton G.D. Laminin alpha2 deficiency-associated muscular dystrophy in a Maine coon cat. J Small Anim Pract 2003, 44:550-552.
10. O'Brien D.P., Johnson G.C., Liu L.A., et al. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci 2001, 189:37-43.
11. Bansal D., Miyake K., Vogel S.S., et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
12. Bashir R., Britton S., Strachan T., et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998, 20:37-42.
13. Liu J., Aoki M., Illa I., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998, 20:31-36.
14. Wang Z., Chamberlain J.S., Tapscott S.J., Storb R. Gene therapy in large animal models of muscular dystrophy. ILAR J 2009, 50:187-198.
15. McClorey G., Moulton H.M., Iverson P.L., Fletcher S., Wilton S.D. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther 2006, 13:1373-1381.
16. Yokota T., Lu Q.L., Partridge T., et al. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 2009, 65:667-676.
17. Liu L.A., Engvall E. Sarcoglycan isoforms in skeletal muscle. J Biol Chem 1999, 274:38171-38176.
18. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999, 41:95-98.
19. Fritschy J.M. Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur J Neurosci 2008, 28:2365-2370.
20. Ramos-Vara J.A. Technical aspects of immunohistochemistry. Vet Pathol 2005, 42:405-426.
21. Montero C. The antigen-antibody reaction in immunohistochemistry. J Histochem Cytochem 2003, 51:1-4.
22. Lo H.P., Cooper S.T., Evesson F.J., et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 2008, 18:34-44.
23. Pramono Z.A., Tan C.L., Seah I.A., et al. Identification and characterization of human dysferlin transcript variants: implications for dysferlin mutational screening and isoforms. Hum Genet 2009, 125:413-420.
24. Piccolo F., Moore S.A., Ford G.C., Campbell K.P. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol 2000, 48:902-912.